|
TRIT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91768823043503E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.86874993047104E-12 |
| Normal-vs-Stage2 |
4.70479999958862E-07 |
| Normal-vs-Stage3 |
1.49179557595858E-11 |
| Normal-vs-Stage4 |
1.99273930689969E-12 |
| Stage1-vs-Stage2 |
7.852400E-01 |
| Stage1-vs-Stage3 |
2.702000E-01 |
| Stage1-vs-Stage4 |
2.223300E-03 |
| Stage2-vs-Stage3 |
3.590800E-01 |
| Stage2-vs-Stage4 |
1.466370E-02 |
| Stage3-vs-Stage4 |
6.799800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55431223447522E-13 |
| Normal-vs-AfricanAmerican |
4.039000E-03 |
| Normal-vs-Asian |
3.01519997858435E-09 |
| Caucasian-vs-AfricanAmerican |
1.650010E-01 |
| Caucasian-vs-Asian |
3.561800E-01 |
| AfricanAmerican-vs-Asian |
4.821600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.44409986378025E-10 |
| Normal-vs-Female |
1.68909330966471E-12 |
| Male-vs-Female |
1.834840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.36575212145362E-12 |
| Normal-vs-Age(41-60Yrs) |
9.44011535608524E-12 |
| Normal-vs-Age(61-80Yrs) |
2.11549999740157E-10 |
| Normal-vs-Age(81-100Yrs) |
4.492300000003E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.648400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.727200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.844800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.464200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.391400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.878200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.23860000034171E-08 |
| Classical-VS-Follicular |
5.223100E-03 |
| Classical-VS-Other |
4.834400E-01 |
| Classical-VS-Normal |
1.66389124700572E-12 |
| Tall-VS-Follicular |
2.10199968542213E-10 |
| Tall-VS-Other |
9.534400E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.665200E-01 |
| Follicular-VS-Normal |
1.434810E-04 |
| Other-VS-Normal |
2.718400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62650012849974E-10 |
| Normal-vs-N1 |
7.77788944361646E-12 |
| N0-vs-N1 |
1.955830E-02 |
|
|
